Gastroparesis with Cannabis Use: A Retrospective Study from the Nationwide Inpatient Sample

References

• Usai-Satta P, Bellini M, Morelli O, et al. Gastroparesis: new insights into an old disease. World J Gastroenterol. 2020;26:2333–2348.
   PubMed Web of Science ®Google Scholar
• KASSANDER P. Asymptomatic gastric retention in diabetics (gastroparesis diabeticorum). Ann Intern Med. 1958;48:797–812.
   PubMed Web of Science ®Google Scholar
• Grover M, Farrugia G, Stanghellini V. Gastroparesis: a turning point in understanding and treatment. Gut. 2019;68:2238–2250.
   PubMed Web of Science ®Google Scholar
• Baumgardner DJ. Suffering in silence: is gastroparesis underdiagnosed? J Patient Cent Res Rev. 2019;6:133–134.
   PubMed Web of Science ®Google Scholar
• Hasler WL. Gastroparesis - current concepts and considerations. Medscape J Med. 2008;10:16.
   PubMedGoogle Scholar
• Pertwee R, ed. Handbook of Cannabis. London, England: Oxford University Press (London, England); 2014. Available at: http://www.oxfordscholarship.eom/view/10.1093/acprof:oso/9780199662685.001.0001/acprof-9780199662685. Published online Jan 2015. Accessed 22 October 2020
   Google Scholar
• Atakan Z. Cannabis, a complex plant: different compounds and different effects on individuals. Ther Adv Psychopharmacol. 2012;2:241–254.
   PubMedGoogle Scholar
• Lafaye G, Karila L, Blecha L, et al. Cannabis, cannabinoids, and health. Dialogues Clin Neurosci. 2017;19:309–316.
   PubMed Web of Science ®Google Scholar
• Healthcare Cost and Utilization Project. Introduction to the HCUP National Inpatient Sample (NIS). The National (nationwide) Inpatient Sample database documentation. Rockville, MD: Agency for Healthcare Research and Quality. Available at: https://www.hcup-us.ahrq.gov/db/nation/nis/NIS_Introduction_2016.jsp and https://www.hcup-us.ahrq.gov/db/nation/nis/NIS_Introduction_2017.jsp. Accessed 2020 Nov 10
   Google Scholar
• Houchens R, Ross D, Elixhauser A, et al. Nationwide Inpatient Sample (NIS) Redesign Final Report. 2014. HCUP Methods Series Report # 2014-04 ONLINE. 2014 Apr 4. U.S. Agency for Healthcare Research and Quality. Available: http://www.hcup-us.ahrq.gov/reports/methods/methods.jsp
   Google Scholar
• Soykan I, Sivri B, Sarosiek I, et al. Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis. Dig Dis Sci. 1998;43:2398–2404.
   PubMed Web of Science ®Google Scholar
• Camilleri M. Cannabinoids and gastrointestinal motility: pharmacology, clinical effects, and potential therapeutics in humans. Neurogastroenterol Motil. 2018;30:e13370.
   PubMed Web of Science ®Google Scholar
• Pacher P, Bátkai S, Kunos G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev. 2006;58:389–462.
   PubMed Web of Science ®Google Scholar
• ElSohly M, Mehmedic Z, Foster S, et al. Changes in cannabis potency over the last 2 decades (1995-2014): analysis of current data in the United States. Biol Psychiatry. 2016;79:613–619.
   PubMed Web of Science ®Google Scholar
• Zamengo L, Prison G, Bettin C, et al. Cannabis potency in the Venice area (Italy): update 2013. Drug Test Anal. 2015;7:255–258.
   PubMed Web of Science ®Google Scholar
• Niesink R, Rigter S, Koeter M, et al. Potency trends of 9-tetrahydrocannabinol, cannabidiol and cannabinol in cannabis in the Netherlands: 2005-15: potency trends of Dutch cannabis. Addiction. 2015;110:1941–1950
   PubMed Web of Science ®Google Scholar
• Carliner H, Brown QL, Sarvet AL, et al. Cannabis use, attitudes, and legal status in the U.S.: a review. Prev Med. 2017;104:13–23.
   PubMed Web of Science ®Google Scholar
• United States Department of Health and Human Services. Substance abuse and mental health services administration. Office of applied studies. National survey on drug use and health ICPSR29621-v1. Ann Arbor, MI: Inter-university Consortium for Political and Social Research [distributor]; 2009. 2010-11-16.Accessed 2020 Oct 22nd.
   Google Scholar
• Calakos KC, Bhatt S, Foster DW, et al. Mechanisms underlying sex differences in cannabis use. Curr Addict Rep. 2017;4:439–453.
   PubMedGoogle Scholar
• Compton WM, Han B, Jones CM, et al. Marijuana use and use disorders in adults in the USA, 2002–14: analysis of annual cross-sectional surveys. Lancet Psychiatry. 2016;3:954–964.
   PubMed Web of Science ®Google Scholar
• Pacek LR, Malcolm RJ, Martins SS. Race/ethnicity differences between alcohol, marijuana, and co-occurring alcohol and marijuana use disorders and their association with public health and social problems using a national sample. Am J Addict. 2012;21:435–444.
   PubMed Web of Science ®Google Scholar
• Howlett AC, Johnson MR, Melvin LS, et al. Nonclassical Cannabinoid analgetics inhibit adenylate cyclase: development of a cannabinoid receptor model. Mol Pharmacol. 1988;33:297–302.
   PubMed Web of Science ®Google Scholar
• Izzo AA, Camilleri M. Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects. Gut. 2008;57:1140–1155.
   PubMed Web of Science ®Google Scholar
• Wright KL, Duncan M, Sharkey KA. Cannabinoid CB(2) receptors in the gastrointestinal tract: a regulatory system in states of inflammation. Br J Pharmacol. 2008;153:263–270.
   PubMed Web of Science ®Google Scholar
• Wright K, Rooney N, Feeney M, et al. Differential expression of cannabinoid receptors in the human colon: cannabinoids promote epithelial wound healing. Gastroenterology. 2005;129:437–453.
   PubMed Web of Science ®Google Scholar
• Mathison R, Ho W, Pittman QJ, et al. Effects of cannabinoid receptor-2 activation on accelerated gastrointestinal transit in lipopolysaccharide-treated rats. Br J Pharmacol. 2004;142:1247–1254.
   PubMed Web of Science ®Google Scholar
• Lehmann A, Blackshaw LA, Brandon L, et al. Cannabinoid receptor agonism inhibits transient lower esophageal sphincter relaxation and reflux in dogs. Gastroenterology. 2002;123:1129–1134.
   PubMed Web of Science ®Google Scholar
• Hinds NM, Ullrich K, Smid SD. Cannabinoid 1 (CB1) receptors coupled to cholinergic motorneurones inhibit neurogenic circular muscle contractility in the human colon. Br J Pharmacol. 2006;148:191–199.
   PubMed Web of Science ®Google Scholar
• Esfandyari T, Camilleri M, Busciglio I, et al. Effects of a cannabinoid receptor agonist on colonic motor and sensory functions in humans: a randomized, placebo-controlled study. Am J Physiol Gastrointest Liver Physiol. 2007;293:137–145.
   PubMed Web of Science ®Google Scholar
• Pertwee RG. Cannabinoids and the gastrointestinal tract. Gut. 2001;48:859–867.
   PubMed Web of Science ®Google Scholar
• Esfandyari T, Camilleri M, Ferber I, et al. Effect of a cannabinoid agonist on gastrointestinal transit and postprandial satiation in healthy human subjects: a randomized, placebo-controlled study. Neurogastroenterol Motil. 2006;18:831–838.
   PubMed Web of Science ®Google Scholar
• Abalo R, Cabezos PA, Lopez-Miranda V, et al. Selective lack of tolerance to delayed gastric emptying after daily administration of WIN 55,212-2 in the rat. Neurogastroenterol Motil. 2009;21:1002–1080.
   PubMed Web of Science ®Google Scholar
• Hyman SM, Sinha R. Stress-related factors in cannabis use and misuse: implications for prevention and treatment. J Subst Abuse Treat. 2009;36:400–413.
   PubMed Web of Science ®Google Scholar
• Zapata Roblyer MI, Betancourth S, Grzywacz JG. Risk and protective factors for lifetime Marijuana use among Colombian emergent adults attending college. ISSBD Bull. 2015;2015:5–9.
   PubMedGoogle Scholar
• Rusznák K, Csekő K, Varga Z, et al. Long-term stress and concomitant Marijuana smoke exposure affect physiology, behavior and adult hippocampal neurogenesis. Front Pharmacol. 2018;9:786.
   PubMed Web of Science ®Google Scholar
• Alshaarawy O, Elbaz HA. Cannabis use and blood pressure levels: United States national health and nutrition examination survey, 2005-2012. J Hypertens. 2016;34:1507–1512.
   PubMed Web of Science ®Google Scholar
• Henry JA, Oldfield WL, Kon OM. Comparing cannabis with tobacco. BMJ. 2003;326:942–943.
   PubMed Web of Science ®Google Scholar
• Danielsson AK, Lundin A, Yaregal A, et al. Cannabis use as risk or protection for type 2 diabetes: a longitudinal study of 18 000 swedish men and women. J Diabetes Res. 2016;2016:6278709.
   PubMed Web of Science ®Google Scholar
• Alshaarawy O, Anthony JC. Cannabis smoking and diabetes mellitus: results from meta-analysis with eight independent replication samples. Epidemiology. 2015;26:597–600.
   PubMed Web of Science ®Google Scholar
• Tashkin DP. Does smoking marijuana increase the risk of chronic obstructive pulmonary disease? CMAJ. 2009;180:797–798.
   PubMed Web of Science ®Google Scholar
• Nassar Y, Richter S. Gastroparesis in non-diabetics: associated conditions and possible risk factors. Gastroenterology Res. 2018;11:340–345.
   PubMed Web of Science ®Google Scholar
• Bielefeldt K. Gastroparesis: concepts, controversies, and challenges. Scientifica (Cairo). 2012;2012:424802.
   PubMedGoogle Scholar
• Bharucha AE. Epidemiology and natural history of gastroparesis. Gastroenterol Clin North Am. 2015;44:9–19.
   PubMed Web of Science ®Google Scholar
• Jung HK, Choung RS, Locke GR, et al. The incidence, prevalence, and outcomes of patients with gastroparesis in Olmsted County, Minnesota, from 1996 to 2006. Gastroenterology. 2009;136:1225–1233.
   PubMed Web of Science ®Google Scholar
• Hirsch W, Nee J, Ballou S, et al. Emergency department burden of gastroparesis in the United States, 2006 to 2013. J Clin Gastroenterol. 2019;53:109–113.
   PubMed Web of Science ®Google Scholar